Elaine H Morrato

Summary

Affiliation: University of Colorado Denver
Country: USA

Publications

  1. doi request reprint The Drug Safety and Risk Management Advisory Committee: a case study of meeting frequency, content, and outcomes before and after FDAAA
    Elaine H Morrato
    Department of Health Systems, Management and Policy, Colorado School of Public Health, CO, USA
    Med Care 50:970-86. 2012
  2. pmc Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes
    Elaine H Morrato
    Departments of Pediatrics, Health Services Management and Policy, and Clinical Pharmacy, University of Colorado Denver, Aurora, Colorado, USA
    Diabetes Care 32:1037-42. 2009
  3. doi request reprint Metabolic screening in children receiving antipsychotic drug treatment
    Elaine H Morrato
    Department of Health Systems, Management, and Policy, Colorado School of Public Health, University of Colorado at Denver, Aurora, Colorado 80045, USA
    Arch Pediatr Adolesc Med 164:344-51. 2010
  4. doi request reprint Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs
    Elaine H Morrato
    Department of Pediatrics, School of Medicine, University of Colorado Denver, Aurora, CO 80045, USA
    Arch Gen Psychiatry 67:17-24. 2010
  5. doi request reprint Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users
    Elaine H Morrato
    Department of Health Systems, Colorado School of Public Health, University of Colorado Denver, Aurora, CO 80045, USA
    Pharmacoepidemiol Drug Saf 20:66-75. 2011
  6. ncbi request reprint Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data
    Elaine H Morrato
    Department of Pediatrics, School of Medicine, University of Colorado at Denver, Aurora, CO 80045 0508, USA
    J Clin Psychiatry 69:316-22. 2008
  7. doi request reprint Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients
    Elaine H Morrato
    Department of Pediatrics, School of Medicine, Management and Policy Colorado School of Public Health, University of Colorado Denver, Aurora, CO 80045 0508, USA
    J Clin Psychopharmacol 29:26-32. 2009
  8. ncbi request reprint Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs
    Anne M Libby
    University of Colorado at Denver and Health Sciences Center, School of Medicine, Nighthorse Campbell Native Health Building, PO Box 6508, Campus Box F800, Aurora, CO 80045 0508, USA
    Am J Psychiatry 164:884-91. 2007
  9. ncbi request reprint Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users
    Elaine H Morrato
    Department of Health Systems, Management and Policy, Colorado School of Public Health, University of Colorado Denver, Aurora, CO, USA
    Pharmacoepidemiol Drug Saf 20:66-75. 2011
  10. ncbi request reprint Using population-based routine data for evidence-based health policy decisions: lessons from three examples of setting and evaluating national health policy in Australia, the UK and the USA
    Elaine H Morrato
    Department of Pediatrics, Preventive Medicine and Biometrics, and Clinical Pharmacy, University of Colorado at Denver and Health Sciences Center, Aurora, CO 80045, USA
    J Public Health (Oxf) 29:463-71. 2007

Detail Information

Publications13

  1. doi request reprint The Drug Safety and Risk Management Advisory Committee: a case study of meeting frequency, content, and outcomes before and after FDAAA
    Elaine H Morrato
    Department of Health Systems, Management and Policy, Colorado School of Public Health, CO, USA
    Med Care 50:970-86. 2012
    ..We hypothesized that meetings involving the FDA Drug Safety and Risk Management (DSaRM) Advisory Committee might serve as a barometer for the impact of FDAAA on drug safety regulatory decision making...
  2. pmc Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes
    Elaine H Morrato
    Departments of Pediatrics, Health Services Management and Policy, and Clinical Pharmacy, University of Colorado Denver, Aurora, Colorado, USA
    Diabetes Care 32:1037-42. 2009
    ..We evaluated whether glucose and lipid testing increased after the American Diabetes Association (ADA) consensus statement recommending metabolic monitoring for SGA-treated patients...
  3. doi request reprint Metabolic screening in children receiving antipsychotic drug treatment
    Elaine H Morrato
    Department of Health Systems, Management, and Policy, Colorado School of Public Health, University of Colorado at Denver, Aurora, Colorado 80045, USA
    Arch Pediatr Adolesc Med 164:344-51. 2010
    ..To estimate metabolic screening rates, predictors of screening, and incidence of metabolic disturbances in children initiating second-generation antipsychotic (SGA) drug treatment...
  4. doi request reprint Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs
    Elaine H Morrato
    Department of Pediatrics, School of Medicine, University of Colorado Denver, Aurora, CO 80045, USA
    Arch Gen Psychiatry 67:17-24. 2010
    ..The American Diabetes Association (ADA) and American Psychiatric Association (APA) recommended glucose and lipid testing for all patients starting to receive SGA drugs...
  5. doi request reprint Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users
    Elaine H Morrato
    Department of Health Systems, Colorado School of Public Health, University of Colorado Denver, Aurora, CO 80045, USA
    Pharmacoepidemiol Drug Saf 20:66-75. 2011
    ..We estimated glucose and lipid testing rates among SGA-users from three state Medicaid programs and investigated small area variation and patient and geographic determinants of testing...
  6. ncbi request reprint Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data
    Elaine H Morrato
    Department of Pediatrics, School of Medicine, University of Colorado at Denver, Aurora, CO 80045 0508, USA
    J Clin Psychiatry 69:316-22. 2008
    ..This study aimed to determine the prevalence of serum glucose and lipid monitoring in public mental health clients initiating second-generation antipsychotic (SGA) drugs...
  7. doi request reprint Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients
    Elaine H Morrato
    Department of Pediatrics, School of Medicine, Management and Policy Colorado School of Public Health, University of Colorado Denver, Aurora, CO 80045 0508, USA
    J Clin Psychopharmacol 29:26-32. 2009
    ..This study evaluated the association between abnormal blood glucose and lipid values and SGA prescribing patterns...
  8. ncbi request reprint Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs
    Anne M Libby
    University of Colorado at Denver and Health Sciences Center, School of Medicine, Nighthorse Campbell Native Health Building, PO Box 6508, Campus Box F800, Aurora, CO 80045 0508, USA
    Am J Psychiatry 164:884-91. 2007
    ....
  9. ncbi request reprint Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users
    Elaine H Morrato
    Department of Health Systems, Management and Policy, Colorado School of Public Health, University of Colorado Denver, Aurora, CO, USA
    Pharmacoepidemiol Drug Saf 20:66-75. 2011
    ..We estimated glucose and lipid testing rates among SGA-users from three state Medicaid programs and investigated small area variation and patient and geographic determinants of testing...
  10. ncbi request reprint Using population-based routine data for evidence-based health policy decisions: lessons from three examples of setting and evaluating national health policy in Australia, the UK and the USA
    Elaine H Morrato
    Department of Pediatrics, Preventive Medicine and Biometrics, and Clinical Pharmacy, University of Colorado at Denver and Health Sciences Center, Aurora, CO 80045, USA
    J Public Health (Oxf) 29:463-71. 2007
    ..The desire for evidence-based health policy and practice is well established. Routine population-based health information systems play a fundamental role to inform policy decisions and to evaluate their effectiveness...
  11. ncbi request reprint Effectiveness of risk management plans: a case study of pemoline using pharmacy claims data
    Elaine H Morrato
    University of Colorado at Denver and Health Sciences Center, Denver, CO, USA
    Pharmacoepidemiol Drug Saf 16:104-12. 2007
    ..To assess the effectiveness of a pharmaceutical risk management plan using pemoline as a case study and pharmacy claims as the data source...
  12. doi request reprint Variability in spinal surgery outcomes among children's hospitals in the United States
    Mark A Erickson
    Department of Orthopedic Surgery, Children s Hospital Colorado, CO 80045, USA
    J Pediatr Orthop 33:80-90. 2013
    ....
  13. doi request reprint Surgical outcomes research: a progression from performance audits, to assessment of administrative databases, to prospective risk-adjusted analysis - how far have we come?
    Elaine H Morrato
    Department of Pediatrics and the Children s Outcomes Research Program, University of Colorado School of Medicine, Denver, Colorado, USA
    Curr Opin Pediatr 20:320-5. 2008
    ..This evolution follows the natural availability of surgical outcome data and a national call for improved hospital care safety and quality...